Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Shivam Puri, CEO, Cipla Health, discusses the brand proposition of Prolyte ORS, shares strategy that helped brand achieve Rs ...

Cipla Ltd. shares jumped over 10% in early trading on Thursday after the USFDA classified its Goa facility as a "Voluntary ...

Indian shares fell on Wednesday, dragged down by high weightage financials and as drugmaker Cipla extended its post-results ...

Shares of Cipla Ltd. are down as much as 4% on Wednesday, October 30 and are the top losers on the Nifty 50 index. The fall ...

On technical setup, the scrip traded higher than the 5-day, 10-, 150-day and 200-day simple moving averages (SMAs) but lower ...

Shares of pharmaceutical giant Cipla dipped 5 per cent at Rs 1,403 per share on the NSE in Wednesday's intraday deals: Cipla ...

Cipla's shares are in focus as the company reported a 15% YoY increase in consolidated net profit to Rs 1,303 crore for Q2 ...

Cipla Q2 Results Live : Cipla declared their Q2 results on 29 Oct, 2024, showcasing a robust performance with a topline ...

Cipla Ltd, a major player in the Indian pharmaceutical sector, currently trades at ₹1,418. This price reflects a decrease of ...

Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 companies in the NSE Nifty today on ...

The stock rose by 9.88% to reach a day high of Rs 1,557.45 on the Bombay Stock Exchange (BSE).  At 10:41 am, shares of Cipla ...